TI-NKs in NSCLC patients show uniformly poor cytotoxicity and acquire a pro-angiogenic dNK-like phenotype, described as VEGF+ CXCL8+ PlGF+ (37, 42, 47). The gene discussed is VEGFA; the disease is non-small cell lung carcinoma.